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Background: To treat healthy retinal pigmented epithelium (RPE) with the 3-
ns retinal rejuvenation therapy (2RT) laser and to investigate the subsequent 
wound-healing response of these cells. 
Methods: Primary rat RPE cells were treated with the 2RT laser at a range of 
energy settings. Treated cells were fixed up to 7 days post-irradiation and 
assessed for expression of proteins associated with wound-healing. For in vivo 
treatments, eyes of Dark Agouti rats were exposed to laser and tissues collected 
up to 7 days post-irradiation. Isolated wholemount RPE preparations were 
examined for structural and protein expression changes. 
Results: Cultured RPE cells were ablated by 2RT laser in an energy-dependent 
manner. In all cases, the RPE cell layer repopulated completely within 7 days. 
Replenishment of RPE cells was associated with expression of the heat shock 
protein, Hsp27, the intermediate filament proteins, vimentin and nestin, and the 
cell cycle-associated protein, cyclin D1. Cellular tight junctions were lost in 
lased regions but re-expressed when cell replenishment was complete. In vivo, 
2RT treatment gave rise to both an energy-dependent localised denudation of 
the RPE and the subsequent repopulation of lesion sites. Cell replenishment was 
associated with the increased expression of cyclin D1, vimentin and the heat 
shock proteins Hsp27 and αB-crystallin. 
Conclusions:  The 2RT  laser was able  to target the  RPE both  in vitro and  in 
vivo, causing debridement of the cells and the consequent stimulation of a 
wound-healing response leading to layer reformation. 
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1 | INTRODUCTION  
 
The retinal pigment epithelium (RPE) comprises a mono- layer of polygonal epithelial cells which are associated at their 
basal surface with Bruch's membrane and the choriocapillaries, and at their apical face with the outer segments of the 
photoreceptors, with which they inter- digitate.1,2 RPE cells have many specialised functions in support of the homeostasis 
of the retina and dysfunction or loss of these cells will have profound effects on this tissue.1,2 RPE cells are thought, for 
example, to be central to the pathogenesis of age-related macular degeneration (AMD): the accumulation of intracellular 
lipofuscin and deposits such as drusen underneath these cells are believed to cause cellular dysfunction, increased oxidative 
stress, and restricted flow of nutrients to the retina, thus contributing to outer retinal pathology.1,3 
There is increasing evidence that in response to stress or trauma the RPE is able to undertake a wound-healing 
response.4,5 During this process, RPE cells alter expression of membrane transporters,6 matrix metalloproteinases (MMPs),7 
intermediate filaments and small heat shock proteins,8 and other secretable factors.9,10 These changes influence quiescent 
RPE cells to remodel Bruch's mem- brane and re-populate lesion sites allowing restoration of physiological retinal 
functioning.1,7 Studies have con- firmed the participation of the RPE in tissue remodelling subsequent to trauma, choroidal 
rupture, sub-retinal neovascularisation and retinal detachment.11-13 It has been postulated that the stimulation of a wound-
healing response in diseases in which RPE cells are themselves dysfunctional could prove beneficial to improving retinal 
function.11 
Interestingly, an RPE wound-healing response has been detected subsequent to laser photocoagulation,12,14 in which 
thermal burns are applied to the retina to amelio- rate pathology associated with diseases such as diabetic macular edema 
(DME), wet AMD and proliferative dia- betic retinopathy. Although different mechanisms for the positive action of this 
therapy have been postulated,15 it is now thought that the major beneficial effects derive from the RPE. This is because 
treatment is typically performed with green lasers that are only minimally absorbed by the macular pigment xanthophyll 
but strongly absorbed by the pigment-bearing melanosomes of the RPE.16,17 Even at very low energy settings, however, 
experimental studies have indicated that the RPE and the overlying photorecep- tors are destroyed by 
photocoagulation,16,18,19 with obvi- ous visual consequences. 
Crucially, recent studies have shown that it is actually possible to both selectively target the RPE with laser pho- 
tocoagulation and to confine thermal energy within this cell layer, thus avoiding collateral damage to the retina  or 
choroid.20,21 Selective RPE targeting is a highly desir- able concept in the provision of therapy for AMD because it could 
theoretically be applied to the central macula. This principle has been applied to systems such as the selective retinal 
therapy (SRT)5,20,22-24 and the retinal rejuvenation therapy (2RT) lasers.21,25-27 
The 2RT laser is a recently-described system, which selectively targets the RPE by virtue of having a concise 3 ns 
pulse duration.21,25-27 As a consequence, this laser will ablate some or all of the RPE cells within the irradiated zone and 
leave surrounding tissues intact. Studies have demonstrated in rodents that the 2RT laser does not cause a breach in Bruch's 
membrane and that  there is no disruption to retinal neurons or photorecep- tors at clinically relevant energy settings.8,19,28 
It has also been shown that the 2RT laser induces release of acti- vated MMPs7 and pigment epithelial-derived factor 
(PEDF)29 as well as proliferation of local RPE cells and re-tiling of this cell layer.28,30 Theoretically, the stimula- tion of 
such a response would be an ideal means to treat AMD, as it would revitalise the RPE cell layer, clear accu- mulated 
deposits from Bruch's membrane via MMP action and consequently relax any restriction in nutrient passage. Indeed, 
clinical testing has revealed that the 2RT laser does show promise in decreasing drusen and slowing the rate of progression 
in AMD patients.27,30,31 These findings could be crucial for patients suffering from the non-exudative form of AMD, for 
which there is no current recognised treatment. 
Since 2RT-induced RPE ablation has been previously documented, we sought to investigate the reaction of healthy 
cells to this laser, as a means to further under- stand the mechanisms by which this treatment could potentially address 
retinal disease treatment. 
 
 
2 | METHODS  
 
2.1 | Laser system 
 
The 2RT system used was a frequency-doubled Nd:YAG laser with a 532 nm wavelength, a 3 ns pulse duration and a 
fine speckle-beam profile (Ellex R&D Pty Ltd, Ade- laide, South Australia). This laser has a 380 μm spot size in air and 
a spot size of 285 μm when focussed on the ret- ina; focussing was achieved using a 5.4 mm fundus laser contact lens 
(Ocular Instruments, Bellevue, WA). The laser was used at four distinct energy settings, which were each defined based 
on in vivo rat eye studies: 24, 64, 91 and 145 mJ/cm2; only the latter two energy settings were used in the in vivo studies. 
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An explanation of the selection of these energy values is provided as Supporting Information. 
 
 
2.2 | Primary rat RPE cell cultures 
 
RPE cell cultures from rat were selected so that comple- mentary rat in vivo studies could be performed. Dark Agouti 
rats were selected because these animals are pigmented and because a supply was readily available to us. All medium and 




F IG U RE  1 Methodological considerations for analysis of the retinal pigmented epithelium (RPE) in vitro (A–F) and in vivo (G–I). 
(A) Treatment of cells in vitro was undertaken in culture plates exposed to laser on a horizontal platform (arrow) attached to a slit-lamp 
headrest. (B) Appearance of untreated RPE cells in culture after labelling with haematoxylin, showing presence of intracellular pigment 
(e.g., arrow). (C) Immunocytochemical labelling of cells at passage number 1 with the RPE-specific protein RPE65, showing cytoplasmic 
labelling (arrow) and demonstrating specificity and homogeneity of the cultures. (D) Immunocytochemical labelling of cultured cells at 
passage number 1 with ZO-1, showing labelling of cell peripheries (arrow) demonstrating presence of intact tight junctions. (E) Schematic 
image demonstrating pattern of laser irradiation on coverslip: 16 spots were applied (red circles) in a 4 × 4 grid with approximately 5 spot 
widths between each application (white circles). (F) RPE cells fixed immediately after application of 2RT laser (91 mJ/cm2), showing 
position of lased region (yellow circle) and resultant lesion area (cells labelled for α-tubulin). (G) Treatment of rat retina/RPE in vivo; 
operator places anaesthetised rat on bespoke holder attached to patient headrest (red arrow) and laser is applied via slit-lamp delivery 
system linked to a monitor. (H) Illustration of laser application to rat eye via fundus imaging; yellow circles show the position of lased 
regions as visible blanching in the pigmented layer. (I) Preparation of RPE wholemounts from untreated eyes labelled for RPE65, showing 
that cells are confluent and predominantly bi- or multi-nucleate. Cells shown in (C, D, E, F, I) have nuclei counter-labelled with DAPI 
(blue). Scale bars: (B–F, I) = 100 μm 
 
WOOD ET AL. 5 
 
 
where otherwise stated. RPE cultures were established from 10-12 day old Dark Agouti rat pups with a proce- dure based 
on that of Mayerson  et al32 and detailed in  the Supporting Information section. Cultures were established from rat pup 
eyes because RPE cells from this source are known to establish readily, rather than those from adult animals.32 Primary 
cultures were allowed to grow in growth medium: Minimal Essential Medium (MEM)  containing  20%  (v/v)  foetal  
bovine  serum,     2 mM L-glutamine (Sigma-Aldrich) and kanamycin/gen- 
tamicin, for 7-10 days in a normal incubator at 37○C,  5% 
CO2 and saturating humidity. Sub-passaging was under- taken into flasks or onto sterile borosilicate glass cover- slips, at 
a ratio of 1:3, using growth medium containing 10% (v/v) foetal bovine serum. All investigations were carried out at first 
or second passage. Whilst the extent of 
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melanisation showed some variation at this stage, all cells retained some degree of pigment, ensuring laser  targeting. 
 
 
2.3 | Treatment of cells in culture 
 
For laser treatment, confluent cells were treated on glass coverslips, in order to allow subsequent immunocyto- chemical  
labelling. Cells  were transferred  to wells  in  a 
24 well-plate containing medium that was warmed to 37○C and was equivalent to normal growth medium except that it 
lacked phenol red indicator and had only 1% (v/v) foetal bovine serum. Culture plates were then placed on a height-
adjustable bespoke horizontal platform attached to the slit-lamp patient chin rest (Figure 1(A)), 
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on which cells were treated. Laser light was directed and focussed onto the surface of the RPE cell layer in the wells via a 
45○ mirror fixed above the platform on which the cell plate was positioned. Energy loss from the mirror used to direct the 
laser onto cells was determined to be negligi- ble.21 Each coverslip was exposed to 16 laser irradiations 
in a 4x4 grid pattern with approximately 5 beam widths distant from any other in the X-Y plane (Figure 1(E)). Use of this 
grid allowed identification of lased zones in labelled coverslips, even if cells had re-populated the region. Treated cells were 
fixed at the appropriate times with 10% (w/v) neutral buffered formalin (NBF), containing 1% (v/v) methanol for 15 
minutes. Some coverslips were dipped for 30 s in 10% haematoxylin to visualise culture appearance (Figure 1(B)). 
It must be noted that, unlike humans, pigmented Dark-Agouti rats have a relatively uniform pigment level with little 
obvious difference between individuals and therefore energy range finding for each animal was con- sidered unnecessary. 
It is also important to note that although laser settings were defined on threshold values obtained from in vivo studies, the 
same settings were used for the in vitro work, even though, obviously, the treatment characteristics (e.g., light path, 
medium, level of cell pigmentation, etc.) would have differed. This was purely for consistency. 
 
 
2.4 | Immunocytochemical labelling of cultured RPE cells 
 
Fixed cells on coverslips were, sequentially, permeabilised in phosphate buffered saline (PBS; 137 mM NaCl, 5.4 mM KCl, 
1.28 mM NaH2PO4, 7 mM Na2HPO4; pH 7.4) con- 
taining 0.1% (v/v) Triton X-100 (PBS-T) for 15 minutes, further washed in PBS and then blocked in horse serum (3.3%, 
v/v in PBS; PBS-HS). Antibodies used for cell label- ling (Table 1) were diluted as appropriate in PBS-HS and applied to 
individual coverslips overnight at room temper- ature. Detection of labels is described in detail in the Supporting 
Information and was as described previously.33 Labelled cells were examined with epifluorescence micros- copy (Olympus 
Australia Pty Ltd, Edwardstown, South Australia). Photography was undertaken with a DP73 camera attachment 
(Olympus Australia Pty Ltd). 
 
 
2.5 | Quantification of immunocytochemical labelling 
 
Quantification of immunolabelling for cultured RPE cells was performed in one of two ways. The first was applied to 
antibodies where labelling was clearly confined within discrete and discernible individual cells (cyclin D1, vimentin, 
nestin): five of the total of 16 individual lased locations were selected from each coverslip and the cen- tre of the treatment 
area centred in the view field. All cells displaying obvious labelling for the requisite anti- body in the field were scored 
and counts averaged for the five selected areas. This mean value then became a single determination (n); single coverslips 
treated from 6 differ- ent cultures, each of which was derived from a separate primary culture, and immunolabelled at 
different times were thus used to produce  6 individual determinations  (n = 6). The second quantification method was 
applied to antibodies which either labelled large numbers of over- lapping cells (e.g., α-tubulin) or which could not distin- 
guish cellular boundaries (e.g., Hsp27): here, Image J was 
used to quantify “labelling area” per field for the requisite 
antibody  and then,  as before,  this value  averaged  from 
5 lased regions per coverslip for 6 separate coverslips    (n = 6). In the case of the Hsp27 labelling quantification, data 
were expressed relative to that obtained for  α-tubulin to account for the changing number of cells present within the 
quantified image. 
Comparison of values obtained at each time-point for each labelling experiment at each laser energy versus sham, 
untreated controls, was carried out by one-way Analysis of Variance (ANOVA) followed by Dunnett's multiple 
comparison test. In some specific cases, in order to determine whether effects of the laser were different at two or more 
laser settings, comparison was made between the means of all groups by undertaking a one-way ANOVA followed by 
Tukey's multiple comparison test. 
 
 
2.6 | Animals 
 
This study was approved by the SA Pathology/Central Heath Network Animal Ethics Committee (Adelaide, Australia) 
and conformed with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 2013, and 
with the ARVO Statement for the use of animals in vision and ophthalmic research. Adult Dark Agouti rats (Aged 6-8 
weeks; approximately 150 g each) were housed in a temperature- and humidity- controlled room with a 12-h light, 12-h 
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dark cycle and were provided with food and water ad libitum. 
Description of animal treatments is detailed in Supporting Information. Animals were treated in both eyes on a custom-
designed platform mounted on a slit- lamp delivery system (Figure 1(G)). Either sham treat- 
ment was applied (“untreated control” at each time point 
for comparative purposes) or actual laser treatment was applied at one of two energy settings (145, 91 mJ/cm2). Typically,  
15-20  laser  spots  were  applied  through  the 
 
TAB LE 1 Antibodies used in the study 
 
Name #Cat No. *Clone Host Company Dilution ICC Dilution IHC Dilution WB 
β-Actin #A5441 Mouse Sigma-Aldrich — — 1:10000 
αB-crystallin *G2JF Mouse Leica — 1:500 1:2000 
Cyclin-D1 #AB21699 Rabbit Abcam 1:20 1:5 — 
Hsp27 #SPA-801 Rabbit Stressgen 1:2000 1:500 1:2000 
Nestin *Rat 401 Mouse BD Transduction 1:1000 — 1:1000 
RPE65 *8B11 Mouse Santa Cruz 1:2500 1:500 1:1000 
α-Tubulin #MU121-UC Mouse BioGenex 1:5000 — — 
Vimentin *V9 Mouse Dako 1:5000 1:250 — 
ZO-1 #61-7300 Rabbit Invitrogen 1:1000 1:250 — 
Note: Addresses: Sigma-Aldrich, Castle Hill, NSW, Australia; Leica, North Ryde, NSW, Australia; Abcam, Cambridge, UK; Stressgen, Victoria, BC, Canada; BD 
Transduction Labs, Lexington, KY, USA; Santa Cruz Biotechnology, Santa Cruz, CA, USA; BioGenex, Fremont, CA, USA; Dako, Sydney, NSW, Australia; 
Invitrogen, Mulgrave, Victoria, Australia. 
Abbreviations: ICC, immunocytochemistry on cell cultures; IHC, immunohistochemistry on RPE-choroid wholemounts; WB, Western blotting. Note: IHC was 
conducted as a 2-step protocol and ICC as a 3-step protocol (see Materials and Methods). 
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cornea and onto the retina for each eye. Treatment avoided overlapping spots, the optic nerve head region or any major 
blood vessels (Figure 1(H)). Treated animals were killed at the following times: 0 h (immediately after laser treatment), 6 
h, 24 h, 72 h and 7 days. Eight animals were treated per laser setting for each time-point. 
 
 
2.7 | Preparation and labelling of RPE- choroid wholemounts 
 
Animals were perfused with sterilised, physiological saline (0.9%, w/v) followed by NBF, under terminal anaesthesia. Both 
eyes were enucleated and retinal wholemounts pre- pared and labelled via immunohistochemistry as described in the 
Supporting Information section. Primary antibodies used (αB-crystallin, cyclin-D1, Hsp27, RPE65, vimentin, ZO-1) are 
detailed see Table 1). Immunohistochemical labelling is also described in detail in the Supporting Infor- mation section. 
Data from 4 separate eyes per time point were collected for statistical comparisons (n = 4). Since immunohistochemistry 
was being used to determine ele- vations in specific antigen expression versus background, data were compared for 
different time-points against that obtained from time zero; one-way ANOVA followed by post-hoc Dunnett's testing was 
employed for significance comparisons. 
 
 
2.8 | Scanning electron microscopy (SEM) 
 
Eyes for SEM were enucleated from terminally anaesthetised animals after transcardial perfusion with physiological saline 
(0.9% w/v) alone. Eye-cups of RPE- choroid were prepared as described above except that tis- sue remained non-fixed at 
this stage. After dissection into wholemounts, tissues were immersed into 3 mL of elec- tron microscopy fixative (4% w/v, 
paraformaldehyde plus 1.25% w/v glutaraldehyde and 4% w/v sucrose, pH 7.2, in 
PBS) at 4○C for 1 h. Subsequent to this, wholemounts 
were washed in 4% w/v sucrose in PBS for 5 minutes and then post-fixed in 2% w/v osmium tetroxide in PBS for   1 h at 
room temperature. Progressive dehydration was then carried out via sequential 15 minute washes in 70% v/v ethanol (x2), 
90% v/v ethanol (x2) and absolute etha- nol (x3). In the final immersion in absolute ethanol, eye- cups underwent critical 
point drying in a Tousimis Super- citical 931.GL Autosamdri (Tousimis, Rockville, MD). Tissue was then mounted on 
metal stubs and carbon coated. Morphological imaging of treated and non-treated RPE-choroid wholemounts was 




2.9 | Electrophoresis and western blotting 
 
Eye-cups of RPE-choroid were prepared as described for SEM and then immersed in 2 mL PBS. A round-head syn- thetic 
nylon filament artists' paintbrush (size 2) was used to brush RPE cells from Bruch's membrane into the immersing PBS. 
RPE cells were collected by centrifuga- tion, and cellular extracts prepared and electrophoresis and Western 
immunoblotting performed as detailed  in the Supporting Information section and as described pre- viously.33 Protein 
concentrations were equalised in 
 
samples by undertaking a bicinchoninic acid assay, as per manufacturer's instructions (Sigma-Aldrich). Label- ling on 
blots was quantified (see Supporting Information section) and normalised for levels of β-actin. Samples were prepared 
from treated animals after 0, 6 and 24 h and data were compared using one-way ANOVA followed by Tukey's multiple 
comparisons test for signifi- cance, with n = 4 samples per determination. 
 
 
3 | RESULTS  
 
3.1 | Effect of laser treatment on cultured RPE cells 
 
Cultured rat RPE cells formed a homogeneous monolayer and retained pigment at the time of treatment (Figure 1 (B)). 
The cells labelled positively for RPE65 (Figure 1(C)) and ZO-1 (Figure 1(D)), both of which are strongly expressed by 
RPE cells in vivo. They also labelled for the structural protein α-tubulin (Figure 1(E)), which was employed to assess the 
effects of laser treatment as it labelled the cells cleanly and homogeneously (Figure 1 (F)); this image corresponded to the 
appearance of the RPE cells prior to laser treatment. Application of 2RT laser to confluent RPE cells at first passage 
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resulted in 
clear and energy-level-dependent effects (Figure 2(A–N)). 
A denuded region was induced in the RPE cell layer with immediate  effect  with  the  laser   energy   set   above  64 
mJ/cm2; at 24 mJ/cm2, there was no observable lesion in the RPE monolayer. The lesions directly produced at the settings 
of 64, 91 and 145 mJ/cm2 were all of signifi- cant size as compared  with  control,  non-treated  cells  (p < 0.001 by one-
way ANOVA followed by Dunnett's multiple comparison test Figure 2(O)) and not signifi- cantly different from each 
other. 
The laser-induced RPE lesions all decreased in size over time and were re-populated with cells by 3–7 days (Figure 2 (J, K, 
L, P)). At 64 and 91 mJ/cm2, lesions were diminished in size compared with their initial denuded zones by 6 h post-treatment, 
and by 24 h, even the lesion  induced  by 145 mJ/cm2 had a significantly smaller diameter. By 72 h 
after treatment, the remaining denudation produced by the laser at 145 mJ/cm2 but not at any of the lower energy set- tings, was 
still significantly elevated in size when compared with untreated cells; after 7 days no lesions remained signif- icantly 
appreciable after any laser application. 
 
 
3.2 | Expression of Hsp27 
 
After laser treatment, cultured RPE cells close, or adja- cent, to the lesion site expressed Hsp27 by 6 h (Figure 3(A–J)). 
Where induced, labelling partially co- localised with α-tubulin, indicating that it was predomi- nantly based within the 
cytoplasm. Although expression of Hsp27 was qualitatively detectable at 6 h post- treatment with all laser settings (Figure 
3(A–C)), only when the energy was applied at 91 or 145 mJ/cm2 was the level significantly increased above the 
background, non-treated level (Figure 3(K)). Expression of Hsp27 
remained elevated for 72 h after applying the laser  at both 91 and 145 mJ/cm2 (Figure 3).  When  comparing the relative 
abundance of Hsp27 expression induced by the 91 and 145 mJ/cm2 power settings, the lower energy level had a somewhat 
greater  effect  at  6  h,  24 h  and 72 h, although the difference  was  only  significant  at  72 h (p < 0.01). It is noteworthy 
that the majority of the cells labelling for Hsp27  after  72 h  at  the  setting  of  91 mJ/cm2 were within the re-populated 
region where a lesion had healed. Also of interest is the finding that the maximum level of induced Hsp27 expression 
was at 6 h for each setting (Figure 3(K)). There were no cells labelled for Hsp27 after more than 3 days (data not shown). 
 
 
3.3 | Cyclin D1 expression 
 
Relative to untreated cells (Figure 4(J)), Cyclin D1 expression was rapidly induced in cultured RPE  after 2RT laser 
treatment (Figure 4(A–J)). By 6 h after treat- ment with 145 mJ/cm2, a significant number of cells sur- rounding the 
denuded region expressed cyclin D1 in their nucleus (20.3 ± 1.7 cells per field versus 0.7 ± 0.5 in an 
equivalent sized area in control cells; p < 0.001; Figure 4 (K)). Cyclin D1 remained  significantly  elevated  until  72 h, 
after which it decreased (Figure 4). At 91 mJ/cm2, expression of cyclin D1 was also significantly increased 
above  background  levels  after  6–72 h  (Figure  4).  At 
64 mJ/cm2, a significant induction of Cyclin D1 was only apparent after 6 h. All cells, regardless of laser setting applied, 
had returned to background cyclin  D1 expression levels by 7 days post-treatment (Figure 4(K)). No significant labelling 
for cyclin D1 was detected after  7 days; appearance of labelled cells was similar to untreated cells (Figure 4(J)); although 



















F IG U RE  2 Appearance of cultured RPE 
cells after treatment with 2RT laser. All cells 
shown have been immunocytochemically 
labelled with the cytoskeletal protein, 
α-tubulin, and counter-stained with the 
nuclear label, DAPI. Culture appearance and 
density as a result of treatment with laser set 
at an energy level of (A, D, G, J) 145 mJ/cm2, 
(B, E, H, K) 91 mJ/cm2 and (C, F, I, L) 
64 mJ/cm2. Arrows denote centre of lased 
zones in each case. (A–C) Cells fixed 
immediately after treatment, to show lesion 
appearance in RPE cell monolayer directly as 
a result of laser treatment. (D–F) Cells fixed 
6 h, 24 h (G–I) and 72 h (J–L) after 
treatment, to show how lesion size and 
appearance changed over time. 
(M) Demonstrates how reduction of the laser 
energy level further (24 mJ/cm2) does not 
cause any visible lesion in RPE cell layer. 
(N) Magnified image of cells abutting the 
periphery of a laser-induced lesion 
(145 mJ/cm2) at 6 h post-treatment showing 
cells present within the laser-treated region. 
(O) Graph showing the relationship between 
the size of the initial laser lesion and the 
applied energy level: ***p < 0.001 when 
comparing size of initial laser lesion at each 
setting versus untreated control, by one-way 
ANOVA followed by Dunnett's multiple 
comparison test (n = 8). (P) Graph showing 
how the size of the laser lesion decreases over 
time, with each of the energy settings 
applied. ***p < 0.001, **p < 0.01 when 
comparing size of lesion versus control cells, 
by one-way ANOVA followed by Tukey's 
comparison test (n = 16 values per 
determination). Scale bars: (A–M) = 100 μm; 












3.1 | Intermediate filament proteins 
 
After 2RT laser treatment of cultured RPE cells, cytoplas- mic expression of the intermediate filament protein vimentin 
was observed, which was not present in un- 
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treated cells. When present, vimentin expression was always localised either to cells in the treated zone or to cells at the 
margins of this region. At 24 mJ/cm2, vimentin was only significantly increased after 6 h, whereas at 64 mJ/cm2 and at 91 
mJ/cm2 this protein was significantly elevated at both 6 and 24 h although not by 72 h. However, at 145 mJ/cm2, vimentin 
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F IG U RE 3 Induction of heat shock protein 27 (Hsp27) expression after treatment of cultured RPE cells with 2RT laser at energy 
settings of 64 mJ/cm2 (A, D, G), 91 mJ/cm2 (B, E, H), 
145 mJ/cm2 (C, F, I); control, untreated cells are also shown (J). All cells shown have been labelled for α-tubulin (green), and Hsp27 (red), 
and counter-stained with the nuclear label, DAPI (blue). 
Cells expressing Hsp27, where labelling co-localises with α-tubulin, appear yellow. Cells were analysed at 6 h (A–C), 24 h (D–F), and 72 h 
(G–I). (K) Quantification of labelling for Hsp27. ***p < 0.001, 
**p < 0.01, *p < 0.05, when comparing data obtained at each energy setting versus untreated control values, for each time-point, by one-way 
ANOVA followed by Dunnett's multiple comparison test (n = 3–6 values per determination). Scale bar: 100 μm 
 
 
The intermediate filament protein, nestin  was induced in a similar manner to  vimentin.  Nestin  was not present in 
untreated cells, but laser application to cultured RPE cells led to expression of nestin in cells immediately surrounding 
the treated zone or in repopulating cells within this region after 6 h or more (Figure 5(M–R,T)). At 64 mJ/cm2, 
expression of nestin was significantly elevated only after 6 h (Figure 5(T)), at 91 mJ/cm2 after 6, 24 and 72 h with a 
maximum induc- tion at 24 h (Figure 5(M–O,T)), and at 145 mJ/cm2 after 
6, 24, 72 h and 7 days with the maximum stimulation after  72 h  (Figure  5(P–R,T)).  Use   of   the   laser   at 24 mJ/cm2 














3.2 | Tight junctions 
 









































FI GU RE 4 Induction of cyclin D1 expression in cultured RPE cells subjected to 2RT laser at energy settings of 91 mJ/cm2 (A–C) and 
145 mJ/cm2 (D–I, K, L); control, untreated cells are also shown (J). All cells shown have been labelled for α-tubulin (green) and 
cyclin D1 (red), and counter-stained with the nuclear label, DAPI (blue). Cells were fixed at 6 h (A, D, G), 24 h (B, E, H) or 72 h (C, F, I). 
Images shown in (G–I) represent higher magnification images of 
cells treated as in (D–F). Labelling at 1 h (K) and 7 days (L) is also 
shown for 145 mJ/cm2. (M) Quantification of cyclin D1 expression. 
***p < 0.001, **p < 0.01, *p < 0.05, when comparing data obtained at each energy setting versus untreated control values, for each time-
point, by one-way ANOVA followed by Dunnett's multiple comparison test (n = 6 values per determination). Scale bars are all 














tight junction machinery (Figure 6(A)). At 6 h after treat- ment with the 2RT laser, there was an ablation of RPE cells 
with the corresponding loss of ZO-1  protein  (Figure 6(B)). At this stage, cells outside of the treated region still retained 
some ZO-1 (Figure 6(B)). As the cells re-populated the lesion site and came into contact with one another, there was a 
renewed expression of ZO-1,  although it was somewhat disorganised (Figure 6(C)). 




F IG U RE 5 Induction of expression of the intermediate filament proteins, vimentin (A–I, M) and nestin (J–L, N), in cultured RPE cells 
after treatment with 2RT laser. (A–I) Cells shown have been labelled for α-tubulin (green), and vimentin (red; 
arrows) and counter-stained with the nuclear label, DAPI (blue). Cells were treated with laser setting at 91 mJ/cm2 (A–C) and 
145 mJ/cm2 (D–L) and fixed after 1 h (J), 6 h (A, D, G), 24 h (B, E, 
H), 72 h (C, F, I) or 7 days (K, L). Images shown in (G–I, L) represent higher magnification images of cells treated as in (D–F, K), 
respectively. (P) Quantification of vimentin expression by 2RT laser at different energy settings and times post-treatment. (M–R) Cells 
treated with laser at 91 mJ/cm2 (M–O) or 145 mJ/cm2 (P–R), 
fixed after 6 h (M, P), 24 h (N, Q) or 72 h (O, R) and then labelled for α-tubulin (green), and nestin (red; arrows) and counter-stained with 
the nuclear label, DAPI (blue). (Q) Quantification of nestin expression. ***p < 0.001, **p < 0.01, *p < 0.05, when comparing data obtained 
at each energy setting versus untreated control values, for each time-point, by one-way ANOVA followed by Dunnett's multiple comparison 
test (n = 6 values per determination). Scale bars are all 100 μm: scale bar shown in 
(F) relates to magnification shown in (A–F); scale bar shown in 
(I) is representative of the magnification used for (G–I); scale bars shown in (J–L) relate to the single images in which they are based; scale 
bar shown in (R) relates to the magnification shown in images (M–R) 
 
 
After 7 days, when the lesion site had completely healed, the cells in this location had regained a normal pattern of ZO-1 
expression (Figure 6(D)). 
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3.3 | Effect of 2RT laser on RPE cells in vivo 
 
RPE cells analysed in wholemount preparations had a homogeneous appearance, but were clearly multi- nucleate (Figure 
1(I)). 
Two energy settings were tested for the 2RT laser     in vivo: 91 and 145 mJ/cm2. Scanning electron micros- copy 
(SEM) imaging of wholemounts prepared immedi- ately after laser treatment at 91 mJ/cm2 and 145 mJ/cm2, revealed the 
denuded region of the RPE monolayer and underlying Bruch's membrane (Figure 7(A,E), respec- tively). After 24 and 
72 h, cells had reappeared in the denuded zone (Figure 7(B,F) and (C,G), respectively). Higher power electron  
microscopy  revealed  that  after  7 days cells had replenished the ablated region. Imaging revealed that the RPE cell layer 
was once again intact (Figure 7(D,H)). 
Labelling for ZO-1 in untreated eyes revealed cell perimeters and allowed dissemination of RPE cells in relation to 
the laser lesion site (Figure 7(M)). When laser was applied at the visible effect threshold of 145 mJ/cm2, a region was 
observed in which ZO-1 labelling was absent and Bruch's membrane was revealed. The lesion was still clearly visible at 
1, 3 and 7 days post-treatment, indicating that at this energy level there was incomplete 
functional repair of the RPE monolayer in this time- frame (Figure 7(N–P)). However, between 3 and 7 days after lasing, 
irregularly-shaped cells re-populated the edges of this region as demonstrated by the reappearance of ZO-1 (Figure 7(P)). 
After application of laser at the lower setting of 91 mJ/cm2 there was a similar pattern of labelling up to 3 days (Figure 
7(I–K)). However, the lesion  was   repaired   by   7 days   post-treatment (Figure 7(L)). 
The RPE-specific protein, RPE65, was clearly and dis- tinctly labelled in cells in wholemounts from both untreated 
(Figure 1(I)) and treated (Figure 7(Q–W)) ani- mals.  Application  of  laser  at  either   91 mJ/cm2 (Figure 7(Q–T)) or 145 
mJ/cm2 (Figure 7(U–W)) caused visible lesions that could be quantified (Figure 7(X)). In the case of the higher setting 
of the laser, there was a slow, partial replenishment of RPE cells into the denuded region, which was visible by 3 days 
(Figure 7(V)) and more fulsome by 7 days (Figure 7(W,X)). Nevertheless, 
the lesion was still only partially healed at this time (Figure 7(W,X)). In contrast, treatment at 91 mJ/cm2 cau- sed a lesion 
that was partially replete with cells by 24 h (Figure 7(R,X)), had much of the denuded zone replenished by 3 days (Figure 
7(S,X)) and, remarkably, was almost completely healed by 7 days (Figure 7(T,X)). The application of laser was found to 
be consistent between  individual  eyes  since  quantification  of  lesion 





F IG U RE 6 Immunocytochemical localisation of the tight junction protein, ZO-1, in cultured rat RPE cells and the effect of 2RT laser 
treatment. Cells shown have been labelled with α-tubulin (green), and ZO-1 (red; arrows) and counter-stained with DAPI (blue). (A) Control, 
untreated cells showing clear labelling for ZO-1 at intercellular boundaries. (B) Cells shown 6 h after treatment  with 2RT laser applied at 91 
mJ/cm2; laser-induced lesion site indicated by *. (C) At 72 h after laser exposure, cells have re- populated the lesion area and expression of 
ZO-1 is present but arranged in a disorganised manner. (D) After 7 days, cells at lesion site have regained a normal expression pattern of ZO-
1. Data are shown only for the 91 mJ/cm2 setting for illustrative purposes. 
Scale bar: 100 μm 
 
 
sizes at each time-point showed relatively limited vari- ability (Figure 7(X)). 
 
 
3.4 | Wound-healing response in vivo 
 
Induction of proteins involved in wound-healing and remodelling of the RPE was investigated only with use of the  laser  
at  the  setting  used  in  the  clinical  trials,    91 mJ/cm2, for the sake of clarity. Firstly, cell prolifera- tion as identified by 
immunolabelling with cyclin D1 was detected by 6 h post-treatment (Figure 8(B)). Quantifica- tion of labelling within 200 
μm of the centre of the lased area revealed a maximum labelling after 6 h. Numbers of cells were significantly increased 
above control at 6 h post-treatment (Figure 8(B,C)). 
Vimentin was not present in wholemounts from untreated animals but was clearly induced at 24 and 72 h after laser 
application, in cells at the edges of the lased regions (Figure 8(D,E)). Quantification of vimentin- labelled cells within 200 
μm of the irradiated region delineated that there was a significant increase up to 72 h after treatment, after which there 
was a rapid decline. 
The small heat shock protein family member, αB- crystallin, was not detected in untreated samples, but was rapidly 
and significantly induced in RPE cells in the peri- 
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treated region (Figure 8(G–K)). This was clear at 6 h and was more prominent after 24 h, also revealing that cells had 
become elongated and were in the process of popu- lating the denuded region. By 72 h labelling had decreased and was 
only associated with a small number of cells at the centre of the treated site. By 7 days post- treatment there were no 
longer any cells labelling for this protein. 
The 2RT laser also stimulated expression of Hsp27 (Figure 8(L–N)), which was not present in untreated samples. 
Hsp27 Western immunoblotting revealed that there were significant and detectable increases at 6 and  24 h. 
Immunohistochemical labelling also revealed that 
some RPE cells at the centre of the treated region remained positive for Hsp27 expression after 72 h. 
 
 
4 | DISCUSSION  
 
In the present study we undertook a detailed investiga- tion into the wound-healing response of the RPE to 2RT laser 
treatment, since this process likely underlies the beneficial effect of the laser on dry AMD progres- sion.27,30,31 In 
agreement with previous studies,19,21,29,30 our data clearly show that the 2RT laser caused an energy-dependent and 
selective ablation  of  RPE  cells  in vitro and in vivo, which was likely predominantly via vaporisation, as evidenced by 
the lack of cell material within lesion sites immediately after treatment. Our data also clearly show that the RPE layer 
was subsequently replenished. Rapid RPE layer re-epithelialisation after injury and consequent barrier re-establishment 
is well- described,13,34 including after laser-induced damage.35,36 This process is crucial because if it did not occur, then 
RPE-depletion itself would indirectly damage adjacent photoreceptors, therefore negating the use of this form of therapy. 
What are the actual cellular triggers that stimulate surviving RPE cells to initiate re-epithelialisation? Sug- gestions 
have included physical damage to cells at the insult boundary with the consequent release of cellular constituents, the 
sudden availability of permissive, non- contact-inhibited cell boundaries, and the non- physiological exposure of 
basement membrane.37 For example, the loss of cell-cell contacts after wounding of the RPE cell layer has been found to 
act as a strong stim- ulus for the process of re-epithelialisation.38 It is also likely that sub-lethal stress to adjacent cells 
during a trau- matic incident activates healing mechanisms.37 In the present study, we detected the rapid elevation of 
expres- sion of Hsp27 and αB-crystallin in cells bordering lesion sites. These proteins are both members of the small heat 
shock protein family and can be induced by processes 
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F IG U RE 7 Assessment of the effects 
of 2RT laser application on RPE in vivo. 
Laser was applied to an eye of a live 
animal and RPE wholemounts prepared. 
(A–H) Scanning electron microscopy of 
region treated by laser at 91 mJ/cm2 (A–
D) and 145 mJ/cm2 (E–H), indicating 
lesion in RPE monolayer (shown by red 
asterisks) and revealing underlying 
Bruch's membrane (BM). Times after 
treatment are recorded ((A, E): 0 h; 
(B, F): 24 h; (C, G): 3 days; (D, H): 7 days) 
and arrows indicate where RPE cells have 
re-populated lesion site; during re- 
populations, some cells within the lesion 
site are flattened and lack apical 
microvilli (C, arrowhead). Scale bars are 
as follows: (A, E): 50 μm; (B, F): 40 μm; 
(C, G): 20 μm; (D, H): 10 μm. 
Immunohistochemical labelling of RPE 
wholemounts for the tight junction 
protein, ZO-1 (I–P) and the RPE-specific 
protein, RPE65 (Q–W), at indicated laser 
energy settings and times after treatment. 
Red asterisks indicate lesion sites and 
arrows indicate RPE cell reappearance. 
When applied at 91 mJ/cm2, the lesion 
site was rapidly filled by re-populating 
cells (I–L, Q–T): by 7 days post-treatment 
the RPE monolayer has effectively been 
completely regenerated (L, T). Although 
some replenishment of killed cells occurs 
at 145 mJ/cm2 a visible lesion still existed 
after 7 days (P, W). (P) Quantification of 
post-treatment lesion size diameter 
verified these findings. Scale bar (shown 







such as thermal increases or oxidative stress occurring at the edge of the lesion.39 Induction of small heat shock pro- teins is 
likely to assist in both chaperone-mediated protec- tion of proteins and contribute to ongoing repair of the epithelial layer, 
particularly by virtue of their ability to reg- ulate cytoskeletal actin dynamics40 and the inhibition of apoptosis.41 Hsp27 
induction has been demonstrated previ- ously in RPE cells in response to different stresses.42 αB- crystallin is expressed in 
the RPE during development, and, as a result of retinopathy.43 This protein is also expressed in damaged RPE and Bruch's 
membrane in dry AMD.44,45 αB-crystallin is believed to promote protection of RPE cells from a range of stressors.43 
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The expression of small heat shock proteins such as Hsp27 and αB-crystallin also promotes epithelial- mesenchymal 
transition (EMT),46,47 an epithelial de- differentiation involving the loss of cell polarity and intercellular adhesion, and 
the gain of migratory poten- tial.37 Quiescent layered cells generally undertake this process to repair lesions, before 
reversion to their original states via a reverse process (mesenchymal epithelial tran- sition; MET). EMT is controlled by 
the activation of transcription factors, such as Snail 1 and Snail 2, by sig- nalling pathways such as those mediated by 
transforming growth factor β (TGF-β), bone morphogenetic protein (BMP), or epidermal growth factor (EGF).48 Such 





F IG U RE 8 Stimulation of protein expression in RPE cells exposed to 2RT laser (91 mJ/cm2) in vivo, in RPE wholemounts. (A–C) Cyclin 
D1 expression is induced by laser irradiation (B; 6 h post treatment) in the nuclei of cells at the periphery of the lesion site, as compared with 
untreated cells (A). Quantification of cyclin D1 induction over time, post treatment is shown in (C). (D–F) Induction of vimentin expression. 
Labelling is observed in some cells after 24 h (D), but expression is more pronounced after 72 h (E). Quantification of vimentin induction 
over time (F). (G–K) Induction of αB-crystallin expression. Within 6 h, there is a clear expression of αB-crystallin (G; arrows). Over time, 
these cells repopulate the treated region (H, I) until, by 7 days post-treatment, the lesion has been repaired and expression of αB-crystallin 
has diminished to background levels (J). Quantification of αB-crystallin induction over time (K). (L–N) Induction of Hsp27 labelling in lased 
cells. Hsp27 expression is observed in repopulating cells after 72 h (L); Western blot analysis determined increases in Hsp27 expression; “C”, 
control, t = 0 treated sample, “6” and “24” refer to the time post-laser treatment (M, N). ***p < 0.001, **p < 0.01, *p < 0.05, when comparing 
data obtained at each energy setting versus untreated control values by one-way ANOVA followed by Dunnett's multiple comparison test 
(n = 4 values per determination; n = 4 separate samples for Western blot). Scale bar: (A, B, D, E, G–J, L) = 50 μm 
 
aberrant signalling will alter transcription of E-cadherin, the pivotal event stimulating EMT.48 In the present study, 
activation of small heat shock proteins in cells bordering the lased region is likely to act as one of the initiating events for 
EMT. Pertinent to this, over-expression of αB- crystallin promotes EMT and additionally, suppression of this protein 
inhibits EMT in the RPE in vivo.49 
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Interestingly, several other studies have shown induc- tion of the large heat shock protein, Hsp70, after thermal laser 
application to the RPE.50,51 Elegant studies by Palanker and colleagues, for example, have demonstrated that photo-
thermal treatment of rat eyes induces Hsp70 formation in RPE cells even when targeted at sub-lethal energy levels.51,52 
Recent reports have suggested that 
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along with selective RPE targeting, sub-lethal laser treat- ment of RPE can also produce a positive therapeutic out- come 
for a range of outer retinal diseases such as dry AMD, and it is believed that induced expression of Hsp70 in living cells 
underlies this protective response.15 How- ever, there is no clear evidence to support intracellular Hsp70 having a role in 
EMT induction. 
The first stage of EMT induction in epithelial cells is the deconstruction of intercellular junctions to allow sep- aration 
at cell-cell borders.37,48 This is illustrated in the present study by the loss of the tight junctional protein, ZO-1, in cells 
adjacent to the laser lesion site (Figure 6). As a corollary of this, the reverse process, MET, is also illustrated in the present 
study by the new expression  and correct organisation of ZO-1 after the lesion in the RPE layer has been repaired. The 
second stage of EMT includes the initiation of cell motility, a process that involves the suppression of cytokeratin 
expression and the induction of expression of the intermediate filament protein, vimentin.37,48 In the present study, we 
clearly show  induction  of  vimentin  expression   within   6  h  in vitro, with expression still remaining after 7 days at the 
highest laser energy applied. Furthermore, vimentin was also significantly expressed in RPE cells in vivo from 1 to 7 days 
after laser application. These data clearly illus- trate the induction of EMT. Of interest was the additional detection of 
increased levels of nestin in surviving RPE cells after laser treatment, in vivo. Nestin is also an inter- mediate filament 
protein and is structurally related to vimentin, but it is generally considered to be expressed during development or by 
progenitor cells in the nervous system.53 Nestin expression is also induced in retinal Muller glial cells in response to a wide 
range of injuries, for example experimental glaucoma,54 and there is evi- dence that adult human RPE cells can also express 
this protein in vitro.55 Some evidence also exists, however, associating nestin expression with EMT,56,57 although whether 
this protein plays a key part in the cytoskeletal remodelling associated with this process here, or is just induced as part of 
a generic stress response is unclear. 
RPE cells that transition to mesenchymal-like cells can subsequently undertake a number of processes that contribute 
to cell layer repair. These cellular processes include migration, proliferation or enlargement.37,58  In the present study we 
could not definitively state that RPE migration into the wound site occurred, either in vitro or in vivo, because we did not 
perform migration assays, but it is possible that cell migration contributed to some extent. In vitro, cells appeared within 
the lesion site within 6 h of treatment, but all such cells were labelled positively for active cell division, implying that re- 
epithelialisation also involved some proliferation. Cell proliferation was discerned via positive labelling for 
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cyclin D1. During the G1 phase of the cell cycle, cyclin D1 is synthesised and accumulates in the nucleus; it is degraded 
in the S-phase.59 It therefore acts as an unam- biguous marker of cells undergoing active proliferation. We initially 
detected cyclin D1 in cells surrounding the irradiated region, both in vitro and in vivo, as early as 6 h post-treatment, and 
subsequently in cells that were re- populating this area, for up to 72 h. RPE proliferation after injury or trauma has been 
well-documented34 and, pertinently, has previously been shown 24 h after 2RT treatment in rat eyes8 and in cells 
bordering the treated region in both mouse eyes30 and human Bruch's membrane-RPE-choroid explants.7 RPE 
proliferation has also been demonstrated after SRT laser application5,60,61 and after standard laser photocoagulation.62 
RPE cells are post-mitotic in situ and therefore do not divide under normal circumstances.63 Because of this, it is 
usually thought that reparation to RPE layer lesions is via cell migration. Cell fusion is also thought to play a role, as 
evidenced by the presence of large, multinucleate RPE cells in situ.64 Recent data have proven, however, that RPE cells 
do have the capacity divide in situ, after a range of localised injuries (see Stern and Temple65). Fur- thermore, it has now 
been suggested that the enlarged, multinucleate RPE cells result from incomplete or failed division rather than fusion of 
neighbouring cells.66 We clearly detected cells with the appearance of being stretched or enlarged, during RPE layer 
repair, as reported previously after 2RT,29,30 SRT5,60,61,67 pattern scanning laser68 or standard laser photocoagulation.62  
Cell enlargement can also form a stage in the process of proliferation: the increase  in  cellular  materials  ahead  of cell 
division is necessary to produce functional daugh- ter cells. In the case of the RPE, hypertrophic cells can become a 
problem if they persist, because they do not form physiological associations with outer segments and, therefore, 
photoreceptor loss can result. In the present study, however, cell enlargement occurred before full reparation of the RPE 
and did not persist. 
RPE division is certainly uncommon in humans, only occurring when lesions occur in the monolayer and nor- mal 
cell-to-cell contacts become disturbed.38 When it does occur, RPE proliferation has been suggested to likely occur via 
EMT, which produces fibroblast-like cells, themselves contributing to  local  pathology  (see  Zhou  et al69). Our data do 
show that all of RPE cell prolifera- tion, cell enlargement and multi-nucleation are detected during tissue repair in situ. 
The RPE cells in our untreated whole-mounts, however, are already predomi- nantly multi-nucleate (Figure 1(I)), so 
occurrence of this process is unlikely to constitute a specific stage of the wound-healing response. Furthermore, enlarged 
cells around the periphery of lesions appear within 24 h, 
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which is the same time as cyclinD1-positive cells appear, indicating that cell stretching is occurring concurrently with cell 
proliferation. Regardless of the absolute balance between cell migration, enlargement and proliferation to promote lesion 
repair in our system, however, we have shown that although RPE cells undergo EMT, they do in fact revert to their native 
state after the lesion is rep- opulated. Furthermore, they undertake this process both in vitro and, importantly, in vivo. 
Thus, the procession of RPE cells through EMT and MET is not pathological but is central to the reparative process. 
In conclusion, the combined data demonstrated that ablation of cells within the RPE layer by application of the 2RT 
laser stimulated a repair process in remaining cells, which eventually replenished lesion sites via the process of EMT. 
Since this replenishment is necessarily associated with tissue remodelling, then the selective targeting of the RPE with 
nanosecond pulse lasers such as the 2RT system described here could serve as a useful tool in the consideration of ocular 
disease treatment. Clinical trials are already underway with this laser to investigate this premise.27,30An important 
additional con- sideration in the use of thermal lasers to treat AMD is that even though drusen presence may be lowered 
and visual performance improved, new choroidal neovascularisation (CNV) can be stimulated, particularly at the edge of 
the laser scar.70-73 This is thought to arise via localised inflammatory production of pro-angiogenic factors or through direct 
disruption of Bruch's mem- brane. The 2RT laser neither disrupts Bruch's membrane19 nor induces a significant 
inflammatory response,8,28 in comparison with a standard pho- tocoagulator laser. This provides additional support for the 
preferential use of this laser system for retinal disease treatment. 
Finally, the present study sought to address the direct effects of the 2RT laser on RPE cells, in order to under- stand 
aspects of the mechanism by which it could poten- tially enhance outer retinal functioning. An obvious limitation of this 
study, however, is that it was carried  out on healthy RPE cells in (pseudo-) physiological con- ditions, that is, non-diseased 
tissue. It is crucial that a succeeding study should assess the influence that 2RT treatment could have in situations that 
mimic the rele- vant clinical situation, for example, either AMD, as pres- ented in patients, or in a relevant animal disease 
model.  It is also crucial that future studies address the effects of laser treatment as well as post-laser tissue recovery on 
both the extracellular matrix and the underlying photore- ceptors.  Finally,  RPE cells  are known  to differ in  their 
migratory responses to cues according to age of donor  and time in culture (in vitro “maturity” level).74 It must, therefore, 
be borne in mind that cells having been either 
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derived from adult rats or that had been cultured  for much longer periods of time than in the present study could show 
different responses to 2RT. 
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